ABBV-295
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie · Phase 2 · Recruiting · Enrollment 360
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.